Kako, S., Fujiwara, S., Nakamura, Y., Kawamura, M., Yoshino, N., Takeshita, J., Gomyo, A., Tamaki, M., Kusuda, M., Kimura, S., Hyodo, K., Kawaguchi, S., Umino, K., Minakata, D., Ashizawa, M., Yamamoto, C., Hatano, K., Sato, K., Nakasone, H., Kanda, Y., Halfdanarson, T., Sonbol, M., Kusne, Y., Patnaik, M. (2025). Haploidentical hematopoietic stem cell transplantation using low-dose alemtuzumab is effective for standard-risk hematological malignancies. Blood. https://doi.org/10.1182/blood-2025-5995